BIO.B Bio-Rad Laboratories Inc. Class B

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.  This company has other shares of common stock that are publicly traded. See the "related symbols" tab.

$769.89  +16.94 (2.25%)
As of 11/18/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  11/05/1984
Outstanding shares:  5,082,161
Average volume:  665
Market cap:   $22,211,912,109
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.59
PB ratio:   1.50
PS ratio:   7.45
Return on equity:   43.43%
Net income %:   223.47%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy